Wells Fargo & Company Increases Common Stock Dividend
Get Alerts WFC Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.3%
EPS Growth %: +10.8%
Join SI Premium – FREE
SAN FRANCISCO--(BUSINESS WIRE)-- Wells Fargo & Company (NYSE: WFC) today announced its board of directors approved a quarterly common stock dividend of $0.50 per share, payable Sept. 1, 2026, to stockholders of record on Aug. 7, 2026. The third quarter dividend represents an increase of $0.05 per share, or 11%, from the prior quarter.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260728562261/en/

Wells Fargo sign on a building exterior.
About Wells Fargo
Wells Fargo & Company (NYSE: WFC) is a leading financial services company that has approximately $2.3 trillion in assets. We provide a diversified set of banking, investment and mortgage products and services, as well as consumer and commercial finance, through our four reportable operating segments: Consumer Banking and Lending, Commercial Banking, Corporate and Investment Banking, and Wealth & Investment Management. Wells Fargo ranked No. 38 on Fortune’s 2026 rankings of America’s largest corporations. News, insights, and perspectives from Wells Fargo are also available at Wells Fargo Stories.
Additional information may be found at www.wellsfargo.com
LinkedIn: https://www.linkedin.com/company/wellsfargo
News Release Category: WF-CFH
View source version on businesswire.com: https://www.businesswire.com/news/home/20260728562261/en/
Media
Beth Richek, 980-308-1568
[email protected]
Investor Relations
John Campbell, 415-396-0523
[email protected]
Source: Wells Fargo & Company
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Announces Results and Upsizing of its Cash Tender Offers for Debt Securities
- Wells Fargo Upgrades Yum! Brands (YUM) to Overweight
- The U.S. FDA grants orphan drug designation for Lundbeck's investigational anti-ACTH monoclonal antibody asedebart for treatment of endogenous Cushing's syndrome
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Dividend, Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share